<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04040777</url>
  </required_header>
  <id_info>
    <org_study_id>19-044</org_study_id>
    <nct_id>NCT04040777</nct_id>
  </id_info>
  <brief_title>Cardiometabolic Risk Factors Registry</brief_title>
  <acronym>CARFARE</acronym>
  <official_title>Cardiometabolic Risk Factors Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Austral University, Argentina</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Austral University, Argentina</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      CARFARE (CARDIOMETABOLIC RISK FACTORS REGISTRY) is a registry done in the context of a
      cardiovascular primary prevention program of the Cardiometabolic Unit Officia of the
      Cardiology Department of the Austral University Hospital. The structured and sequential
      evaluation include measurement of anthropometric parameters (body mass index, BMI),
      laboratory with metabolic profile, baseline electrocardiogram, blood pressure (BP)
      measurement, arterial stiffness, subclinical atherosclerosis screening in the carotid and
      ileo-femoral territories using echo-doppler, echocardiogram, and ergometry test.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 2015</start_date>
  <completion_date type="Anticipated">December 2025</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>5 Years</target_duration>
  <primary_outcome>
    <measure>Incidence of Major Adverse Cardiovascular Events (MACE)</measure>
    <time_frame>5 years</time_frame>
    <description>Inicidence of myocardial infarction, stroke, unstable angina or acute heart failure</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mortality rate</measure>
    <time_frame>5 years</time_frame>
    <description>Death due to MACE or other causes</description>
  </primary_outcome>
  <enrollment type="Anticipated">15000</enrollment>
  <condition>Atherosclerosis</condition>
  <condition>Metabolic Syndrome</condition>
  <condition>Diabetes</condition>
  <condition>Cardiovascular Risk Factor</condition>
  <condition>Cardiovascular Diseases</condition>
  <condition>Obesity</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Primary prevention population. Most of the population are low and moderate cardiovascular
        risk.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt;18 years old.

        Exclusion Criteria:

          -  Previous cardiovascular and/or cerebrovascular event

          -  stable chronic angina

          -  advanced chronic kidney disease (Stage IV or V)

          -  cancer
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sergio E. Gonzalez, MD</last_name>
    <role>Study Director</role>
    <affiliation>Austral University, Argentina</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Maximo A Schiavone, MD</last_name>
    <email>maximoschiavone@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital Universitario Austral</name>
      <address>
        <city>Pilar</city>
        <state>Buenos Aires</state>
        <zip>1631</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maximo A. Schiavone, MD</last_name>
      <email>maximoschiavone@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Fabian Ferroni, MD</last_name>
      <email>FFERRONI@cas.austral.edu.ar</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Argentina</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>July 30, 2019</study_first_submitted>
  <study_first_submitted_qc>July 30, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 1, 2019</study_first_posted>
  <last_update_submitted>November 6, 2019</last_update_submitted>
  <last_update_submitted_qc>November 6, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 7, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Austral University, Argentina</investigator_affiliation>
    <investigator_full_name>Maria Julia Cremona</investigator_full_name>
    <investigator_title>Coordinator of Clinical Research Department</investigator_title>
  </responsible_party>
  <keyword>Subclinical Atherosclerosis</keyword>
  <keyword>Metabolic Syndrome</keyword>
  <keyword>Primary Prevention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atherosclerosis</mesh_term>
    <mesh_term>Metabolic Syndrome</mesh_term>
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

